Ever wondered about the people who are leading the fight against cancer, developing groundbreaking treatments, and changing lives? Meet Frank Boriello, the mind behind SUPLEXA cell therapy… Read More
MADRID — Including pembrolizumab (Keytruda) in the first-line treatment of metastatic HER2-positive gastric or gastroesophageal cancer improved progression-free survival (PFS), but… Read More
Buy Now
The US Acute Myeloid Leukemia Market is poised for a steered growth due to advancement in treatment approaches, increases healthcare costs and expenditure, growing investments in Res… Read More
In recent years, PROteolysis TArgeting Chimeras (PROTAC), which utilizes the cell’s own degradation mechanisms to eliminate specific disease-related proteins, has emerged as one of the… Read More
The impact of immunotherapy, specifically immune checkpoint inhibitors, in advanced and metastatic cancer quickly led to interest in using the therapy in earlier-stage disease. Most recent… Read More
Oncology Precision Medicine Market, Size, Global Forecast 2022-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis. The report also includes an a… Read More
DUBLIN–(BUSINESS WIRE)–The “Anti TIGIT Antibody Market Opportunity and Clinical Trials Insight 2024” report has been added to ResearchAndMarkets.com’s offering… Read More
Over the past decade, significant strides have been made in the realm of peptide drug development courtesy of ground-breaking advancements in produc… Read More
[Research Report] The T cell therapy market size was valued at US$ 2,754.0 million in 2022 and is expected to reach US$ 9,035.01 million by 2030. It is estimated to register a CAGR of 1… Read More
The Global Automotive Hypervisor Market: Size and Forecast to 2026, the Most Recent Report from Markntel AdvisorsThe Global Automotive Hypervisor Market research report is one in a… Read More
Adding regorafenib (Stivarga) to a standard first-line chemoimmunotherapy regimen for HER2-negative metastatic esophagogastric cancer demonstrated “promising” activity in a sin… Read More
A comparative analysis of fecal bacteria revealed distinct differences between patients with melanoma and healthy volunteers and between patients with early- versus late-stage melanoma.
Pa… Read More
Multiple factors were associated with an increased risk for venous thromboembolism (VTE) in hospitalized cancer patients with COVID-19, a registry-based cohort study found.
Pooled together… Read More
Liquorice Shellac Market
BROOKLYN, NEW YORK, USA, July 17, 2023/EINPresswire.com/ — In line with IMARC Group’s newest analysis report, titled “Liquorice Shellac Mark… Read More
In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More
Immune checkpoint inhibitors showed activity among people with HIV and various cancer types, without any excess or unexpected toxicities, according to a retrospective real-world study.
In… Read More
Adjuvant therapy with nivolumab (Opdivo) was feasible and safe and appeared to prolong disease-free survival (DFS) in patients with completely resected Merkel cell carcinoma (MCC), interi… Read More
CHICAGO — In patients with metastatic EGFR-positive lung cancer who progressed on targeted agents, adding pembrolizumab (Keytruda) to a standard chemotherapy regimen demonstrated n… Read More
The company will showcase its latest innovative solutions to enable rapid diagnosis, Theranostics, and precision care at #SNMMI23
Clinicians and patients are aligned in what they want: A… Read More
Cancer, one of the leading causes of death globally, has long been a challenge for healthcare professionals to treat effectively. Traditional methods, such as chemotherapy, radiation, and su… Read More
Immuno Oncology Market report delivers detailed overview of the global immuno oncology market in terms of market segmentation by treatment, by novel targets, by tumor type and by region… Read More
Introduction:
In recent years, the field of medicine has witnessed remarkable advancements, and one area that stands out is the development and utilization of biological drugs. These cutting… Read More
CHICAGO — A randomized trial testing the addition of perioperative pembrolizumab (Keytruda) to chemotherapy in operable non-small cell lung cancer (NSCLC) hit one of its two primar… Read More
The combination of oncolytic DNX-2401 virotherapy with pembrolizumab (Keytruda) failed to meet a phase I/II study’s primary endpoint of objective response rate (ORR) in patients with… Read More
Markntel
Advisors has recently documented a thorough report on the Cancer
Immunotherapy market, which
covers the projection period of 2023-2028. The report offers detailed market… Read More
Immunotherapy Drugs Market
Immunotherapy Drugs Market is expected to grow at a CAGR of 10.1% during the forecast period and the market size is expected to reach nearly US$ 402… Read More
Incyte Corp’s programmed death receptor-1 (PD-1) therapy Zynyz (retifanlimab-dlwr) has received the green light from the US Food and Drug Administration (FDA) for the treatment of adul… Read More
During the forecast period, 2021–26, the Cancer Immunotherapy Market is anticipated to expand at a CAGR of about 13.22%. In order to understand the potential future growth of the marke… Read More
The report provides Market.Biz Intratumoral Cancer Therapies Market detail analysis, and supply chain information, Technological advancement, and innovation will further optimize t… Read More
Most of you are familiar with Zeno's paradox regarding the impossibility of motion, Achilles and the tortoise dilemma. Zeno asserts that no matter how quickly Achilles races t… Read More
JEvery year new findings from cancer research are presented at the congress of the European Society for Medical Oncology (ESMO). But what John Haanen from the Dutch Cancer Institute prese… Read More
The post The Cancer Immunotherapy Market Is Expected to Reach Nearly US$ 310 Bn by 2031 appeared first on Newstrail.com authored by Fact.MR
Fact.MR predicts the global sales of cancer immuno… Read More
The Alzheimer’s disease diagnostics and therapeutics market was valued at USD 6,632.82 million in 2022, and it is expected to reach approximately USD 9,073 million in 2031, registering… Read More